TY - JOUR
T1 - Inappropriate activation of the androgen receptor by nonsteroids
T2 - Involvement of the Src kinase pathway and its therapeutic implications
AU - Desai, Sonal J.
AU - Ma, Ai Hong
AU - Tepper, Clifford G.
AU - Chen, Hong Wu
AU - Kung, Hsing Jien
PY - 2006/11/1
Y1 - 2006/11/1
N2 - The inappropriate activation of androgen receptor (AR) by nonsteroids is considered a potential mechanism in the emergence of hormone-refractory prostate tumors, but little is known about the properties of these " pseudoactivated" AR. Here, we present the first comprehensive analysis closely examining the properties of AR activated by the neuropeptide bombesin that distinguish it from androgen-activated AR. We show that bombesin-activated AR (a) is required for bombesin-induced growth of LNCaP cells, (b) has a transcriptional profile overlapping with, but not identical to, androgen-activated AR, (c) activates prostate-specific antigen by preferentially binding to its proximal promoter, and (d) assembles a distinct coactivator complex. Significantly, we found that Src kinase is critical for bombesin-induced AR-mediated activity and is required for translocation and transactivation of AR. Additionally, we identify c-Myc, a Src target gene, to be activated by bombesin and a potential coactivator of AR-mediated activity specific to bombesin-induced signaling. Because Src kinase is often activated by other nonsteroids, such as other neuropeptides, growth factors, chemokines, and cytokines, our findings have general applicability and provide rationale for investigating the efficacy of the Src kinase pathway as a target for the prevention of relapsed prostate cancers.
AB - The inappropriate activation of androgen receptor (AR) by nonsteroids is considered a potential mechanism in the emergence of hormone-refractory prostate tumors, but little is known about the properties of these " pseudoactivated" AR. Here, we present the first comprehensive analysis closely examining the properties of AR activated by the neuropeptide bombesin that distinguish it from androgen-activated AR. We show that bombesin-activated AR (a) is required for bombesin-induced growth of LNCaP cells, (b) has a transcriptional profile overlapping with, but not identical to, androgen-activated AR, (c) activates prostate-specific antigen by preferentially binding to its proximal promoter, and (d) assembles a distinct coactivator complex. Significantly, we found that Src kinase is critical for bombesin-induced AR-mediated activity and is required for translocation and transactivation of AR. Additionally, we identify c-Myc, a Src target gene, to be activated by bombesin and a potential coactivator of AR-mediated activity specific to bombesin-induced signaling. Because Src kinase is often activated by other nonsteroids, such as other neuropeptides, growth factors, chemokines, and cytokines, our findings have general applicability and provide rationale for investigating the efficacy of the Src kinase pathway as a target for the prevention of relapsed prostate cancers.
UR - http://www.scopus.com/inward/record.url?scp=33751267275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751267275&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-06-2582
DO - 10.1158/0008-5472.CAN-06-2582
M3 - Article
C2 - 17079466
AN - SCOPUS:33751267275
SN - 0008-5472
VL - 66
SP - 10449
EP - 10459
JO - Cancer Research
JF - Cancer Research
IS - 21
ER -